Union Jobs Report

PILMA news

PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act

February 25, 2025 PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act Bipartisan legislation would correct the “pill penalty” to safeguard union jobs and ensure continued innovation in small-molecule therapies The Pharmaceutical Industry Labor-Management Association (PILMA) applauds the introduction of the Ensuring Pathways to Innovative Cures (EPIC)

Read More »

President McManus Letter on PBMs to Congress

 November 21, 2024  Dear Speaker Johnson, Leader Jeffries, Leader Schumer, and Leader McConnell,  As Congress returns to Washington for the remaining weeks of the legislative session, lawmakers have a critical opportunity to deliver meaningful reforms that will provide relief to millions of hardworking families struggling with high prescription drug costs. 

Read More »

United Association President McManus Letter to HELP Committee

September 25, 2024 To:The Office of Senator Bernie Sanders, ChairU.S. Senate Committee on Health, Education, Labor, and Pensions332 Dirksen Senate Office Bldg. Washington, D.C., 20510 The Office of Senator Bill Cassidy, Ranking MemberU.S. Senate Committee on Health, Education, Labor, and Pensions455 Dirksen Senate Office Bldg.Washington, D.C., 20510 cc: Members of

Read More »

Facility Tours

PILMA – IUOE LOCAL 150 FACILITY TOUR

Mental Health Lunch and Learn with UA Local 9

Pipefitters Local 455 Apprenticeship Tour and Industry

Labor-Industry Collaboration Highlighted at Astellas West Coast Innovation Center Tour

Eli Lilly Facility Tour

IUOE LOCAL 12 FACILITY TOUR, NEVADA

IUOE LOCAL 12 FACILITY TOUR, NEVADA

PHILADELPHIA STEAMFITTERS LOCAL 420 TRAINING CENTER 

Maryland Senator Chris Van Hollen Tours IBEW Local 26

Resolutions

Reports

Evaluating the Role of 340B in Managing Healthcare Costs for Taft-Hartley Plans

Most-Favored-Nation Drug Pricing: A Threat to American Workers and Innovation

An Understanding and Implications of the Cost Drivers in the Drug Supply Chain

Impact of Medicare Part D Rebates on Multi-employer Plans

Jobs Today: Cures Tomorrow—Innovation and the Biopharmaceutical Industry

Health Care Reform for Workers and Working Families